Ironwood Pharmaceuticals Inc expected to post earnings of 4 cents a share - Earnings Preview

Ironwood Pharmaceuticals

04/08/2025 14:40

Ironwood Pharmaceuticals Inc IRWD.OQ IRWD.O is expected to  show a fall in quarterly revenue when it reports  results on August 6 (estimated) for the period ending June 30 2025

The Boston Massachusetts-based  company is expected to report a 35.6% decrease in revenue to $60.775 million from $94.4 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Ironwood Pharmaceuticals Inc is for earnings of 4 cents per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Ironwood Pharmaceuticals Inc is $1.00, about 22.9% above its last closing price of $0.77

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.06
-0.05
-0.14
Missed
-200
Dec. 31 2025
0.07
0.08
0.02
Missed
-74.4
Sep. 30 2024
0.06
0.08
0.02
Missed
-75.2​
Jun. 30 2024
0.13
0.15
0.00
Missed
-100
​​Mar. 31 2024
0.15
0.19
-0.02
Missed
-110.5
Dec. 31 2023
0.21
0.21
-0.01
Missed
-104.9​
Sep. 30 2023
0.17
0.16
0.09
Missed
-42.9
Jun. 30 2023
0.26
0.25
0.31
Beat
25.7

This summary was machine generated August 4 at 13:40 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)